LivingGLP1
Study S000274

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes: A Multi-center Observational Study

Registration

Registration
NCT04374578
Acronym
DIVE
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
100
Start
2020-05-08
Primary completion
2021-01-31
Lead sponsor
Shanghai Zhongshan Hospital
Conditions
Type 2 Diabetes
Interventions
DRUG:Dulaglutide 1.5 MG/ML
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Effect on glycemic variability [one months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.